/Dongbao Biotechnology: Summary table of non-operating fund occupation and other related fund transactions in the first half of 2025
NEWS

Dongbao Biotechnology: Summary table of non-operating fund occupation and other related fund transactions in the first half of 2025

Shenzhen Stock Exchange
2025/08/29

Annex 1

Summary table of non-operating fund occupation and other related fund transactions in the first half of 2025

Listed company name: Baotou Dongbao Biotechnology Co., Ltd. Unit: 10,000 yuan Half-year 2025 Half-year 2025 Half-year 2025 Half-year 2025

The occupying party and the listed company. The listed company’s initial share in 2025

Occupation of non-operating funds Name of party who occupies the funds Accumulated amount of used funds Interest repayment of accumulated funds occupied at the end of the period Reasons for the occupation Whether to disclose the nature of the occupation Related relationships of the department Accounting items Balance of funds used

(Excluding interest) Interest (if any) Amount Balance

Controlling shareholders, actual controllers and their affiliated companies

Subtotal - - - - -

Former controlling shareholders, actual controllers and their affiliated companies

Subtotal - - - - -

Other related parties and subsidiaries

Subtotal - - - - - Total - - - - - 2025 Half Year 2025 Half Year 2025 Half Year 2025 Half Year

The corresponding parties and listed companies accounted for the opening share of the listed company in 2025.

Other related fund transactions Name of fund transaction party Accumulated amount used Interest on occupied funds Repay accumulative occurrence Funds occupied at the end of the period Reasons for the transaction Whether to disclose the nature of the transaction Related relationships of the company Accounting items Used fund balance

(Excluding interest) Interest (if any) Amount Balance

Guoen Future (Liaoning) Health Technology Development Co., Ltd. Grandson of the controlling shareholder Accounts receivable of the company 18.00 18.00 Sales of collagen series products No Operating transactions with the controlling shareholder, actual controller and their affiliated companies

Subtotal - - - - 18.00 - - 18.00 - -

Inner Mongolia Dongbao Datian Biotechnology Co., Ltd. Wholly-owned subsidiary Other receivables 3,129.57 830.37 3,959.94 Daily borrowings No Subsidiaries and affiliates of non-operating listed companies Inner Mongolia Dongbao Datian Biotechnology Co., Ltd. Wholly-owned subsidiary Other receivables 6,215.13 211.32 6,003.81 Loans for investment projects No Non-business transactions

Qingdao Yiqing Biotechnology Co., Ltd. Wholly-owned subsidiary Other receivables 3,600.00 832.21 62.80 62.80 4,432.21 Loans for investment projects No Subtotal of non-operating transactions - - - 12,944.70 1,662.58 62.80 274.12 14,395.96 - -The controlling shareholder of the company

The original director of Qingdao Hanfang Pharmaceutical Co., Ltd. holds shares and accounts receivable 20.49 1.44 19.05 Rental of office space, water and electricity bills No Operating transactions with other related parties and their affiliated companies Companies serving as directors

Subtotal - - - - 20.49 - 1.44 19.05 - -Total - - - 12,944.70 1,701.07 62.80 275.56 14,433.01 - -

Person in charge of the enterprise: Wang Aiguo Person in charge of accounting work: Hao Haiqing Person in charge of the accounting department: Du Li